Pulse Biosciences Inc
NASDAQ:PLSE
Pulse Biosciences Inc
Accrued Liabilities
Pulse Biosciences Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pulse Biosciences Inc
NASDAQ:PLSE
|
Accrued Liabilities
$3.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$6.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$691.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
See Also
What is Pulse Biosciences Inc's Accrued Liabilities?
Accrued Liabilities
3.4m
USD
Based on the financial report for Mar 31, 2024, Pulse Biosciences Inc's Accrued Liabilities amounts to 3.4m USD.
What is Pulse Biosciences Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
12%
Over the last year, the Accrued Liabilities growth was -16%. The average annual Accrued Liabilities growth rates for Pulse Biosciences Inc have been -19% over the past three years , 12% over the past five years .